These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22962476)

  • 1. Relating drug-protein interaction network with drug side effects.
    Mizutani S; Pauwels E; Stoven V; Goto S; Yamanishi Y
    Bioinformatics; 2012 Sep; 28(18):i522-i528. PubMed ID: 22962476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug target prediction using adverse event report systems: a pharmacogenomic approach.
    Takarabe M; Kotera M; Nishimura Y; Goto S; Yamanishi Y
    Bioinformatics; 2012 Sep; 28(18):i611-i618. PubMed ID: 22962489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of chemogenomic features from drug-target interaction networks using interpretable classifiers.
    Tabei Y; Pauwels E; Stoven V; Takemoto K; Yamanishi Y
    Bioinformatics; 2012 Sep; 28(18):i487-i494. PubMed ID: 22962471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of drug-target interaction networks from the integration of chemical and genomic spaces.
    Yamanishi Y; Araki M; Gutteridge A; Honda W; Kanehisa M
    Bioinformatics; 2008 Jul; 24(13):i232-40. PubMed ID: 18586719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inferring protein domains associated with drug side effects based on drug-target interaction network.
    Iwata H; Mizutani S; Tabei Y; Kotera M; Goto S; Yamanishi Y
    BMC Syst Biol; 2013; 7 Suppl 6(Suppl 6):S18. PubMed ID: 24565527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting drug side-effect profiles: a chemical fragment-based approach.
    Pauwels E; Stoven V; Yamanishi Y
    BMC Bioinformatics; 2011 May; 12():169. PubMed ID: 21586169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational probing protein-protein interactions targeting small molecules.
    Wang YC; Chen SL; Deng NY; Wang Y
    Bioinformatics; 2016 Jan; 32(2):226-34. PubMed ID: 26415726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic side effects prediction by optimizing correlation with chemical and target profiles of drugs.
    Kanji R; Sharma A; Bagler G
    Mol Biosyst; 2015 Nov; 11(11):2900-6. PubMed ID: 26252576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DINIES: drug-target interaction network inference engine based on supervised analysis.
    Yamanishi Y; Kotera M; Moriya Y; Sawada R; Kanehisa M; Goto S
    Nucleic Acids Res; 2014 Jul; 42(Web Server issue):W39-45. PubMed ID: 24838565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive prediction of drug-protein interactions and side effects for the human proteome.
    Zhou H; Gao M; Skolnick J
    Sci Rep; 2015 Jun; 5():11090. PubMed ID: 26057345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting drugs side effects based on chemical-chemical interactions and protein-chemical interactions.
    Chen L; Huang T; Zhang J; Zheng MY; Feng KY; Cai YD; Chou KC
    Biomed Res Int; 2013; 2013():485034. PubMed ID: 24078917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IntSide: a web server for the chemical and biological examination of drug side effects.
    Juan-Blanco T; Duran-Frigola M; Aloy P
    Bioinformatics; 2015 Feb; 31(4):612-3. PubMed ID: 25380960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TargetNet: a web service for predicting potential drug-target interaction profiling via multi-target SAR models.
    Yao ZJ; Dong J; Che YJ; Zhu MF; Wen M; Wang NN; Wang S; Lu AP; Cao DS
    J Comput Aided Mol Des; 2016 May; 30(5):413-24. PubMed ID: 27167132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-scale detection of drug off-targets: hypotheses for drug repurposing and understanding side-effects.
    Chartier M; Morency LP; Zylber MI; Najmanovich RJ
    BMC Pharmacol Toxicol; 2017 Apr; 18(1):18. PubMed ID: 28449705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the associations between drug side-effects and therapeutic indications.
    Wang F; Zhang P; Cao N; Hu J; Sorrentino R
    J Biomed Inform; 2014 Oct; 51():15-23. PubMed ID: 24727480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug target identification using side-effect similarity.
    Campillos M; Kuhn M; Gavin AC; Jensen LJ; Bork P
    Science; 2008 Jul; 321(5886):263-6. PubMed ID: 18621671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network-based characterization of drug-protein interaction signatures with a space-efficient approach.
    Tabei Y; Kotera M; Sawada R; Yamanishi Y
    BMC Syst Biol; 2019 Apr; 13(Suppl 2):39. PubMed ID: 30953486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supervised de novo reconstruction of metabolic pathways from metabolome-scale compound sets.
    Kotera M; Tabei Y; Yamanishi Y; Tokimatsu T; Goto S
    Bioinformatics; 2013 Jul; 29(13):i135-44. PubMed ID: 23812977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemical basis of pharmacology.
    Keiser MJ; Irwin JJ; Shoichet BK
    Biochemistry; 2010 Dec; 49(48):10267-76. PubMed ID: 21058655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting drug-target interactions from chemical and genomic kernels using Bayesian matrix factorization.
    Gönen M
    Bioinformatics; 2012 Sep; 28(18):2304-10. PubMed ID: 22730431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.